Translational Development Acquisition Corp.
NASDAQ:TDACShell Companies
-$0.01 today
- Market cap
- $267.99M
- Beta
- 0.01
- P/E (TTM)
- 29.8
- EPS (TTM)
- $0.36
Volume 0.47M
Average 0.10M
TDAC Short-term Debt
Borrowings and the current portion of long-term debt due within one year.
Translational Development Acquisition Corp.NASDAQ: TDAC
Short-term Debt · Q1 FY2026 · quarter ended Mar 2026
Short-term debt falls 92.0% from a year ago
Short-term debt stood at $500K at the end of Q1 FY2026, down 92.0% from a year earlier and up 150.0% from the prior quarter. Over 3 fiscal years it compounded at -8.3% a year.
Context
- Short-term debt amounted to 0.3% of total assets at the end of Q1 FY2026, down 3.2 pp from a year earlier.
- Short-term debt increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether short-term debt keeps falling in the next quarterly balance sheet after a -92.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Debt history
USD · from the balance sheet
- Latest · FY2025
- 200K USD
- Year-over-year change
- -100.0%
- 3-year CAGR
- -8.3%
| Period | Period end | Short-term Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 200K | -100.0% |
| FY2024 | 2024-12-31 | 6.11T | +1758496878.4% |
| FY2023 | 2023-12-31 | 347.5K | +34.2% |
| FY2022 | 2022-12-31 | 259K | — |
Short-term Debt vs competitors
How TDAC compares with its peers on the latest reported figures
- TDAC's Mar 2026 short-term debt of $500K is the 3rd highest of the 7 companies compared; the peer median is $0.
- Its year-over-year change of -92.0% is the highest of 2, against a peer median of -100.0%.
- Short-term debt amounts to 0.3% of total assets for TDAC, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
MACIMelar Acquisition Corp. I | Mar 2026 | $3.95M | — | — | 2.2% |
| Mar 2026 | $769.53K | — | — | 0.4% | |
| Mar 2026 | $500K | -92.0% | -8.3% | 0.3% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
NTWONewbury Street II Acquisition Corp | Mar 2026 | $0 | — | — | 0.0% |
| Jun 2025 | $0 | — | — | 0.0% | |
| Peer median (excluding TDAC) | $0 | -100.0% | — | 0.0% | |
Competitors are the stored peer set for TDAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Translational Development Acquisition Corp.
NASDAQ:TDAC
Intrinsic Alpha fair value
Locked
Current Price
$10.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.